The Annual International SMA Research & Clinical Care Meeting is the largest of its kind in the world focused on SMA and offering insightful discussion around new research and clinical care practices.

The Annual International SMA Research & Clinical Care Meeting brings together researchers from academia, government, and biotech/pharmaceutical companies with multi-disciplinary healthcare providers who are diagnosing and caring for people with spinal muscular atrophy (SMA). The event is held in conjunction with Cure SMA’s Annual SMA Conference.

More details about the 2021 SMA Research & Clinical Care Meeting will be announced in the upcoming months and registration will launch in Fall/Winter 2020. We look forward to seeing you in Austin!


Questions? Email [email protected] or call 800-886-1762.

2020 Meeting Goes Virtual!

The current state of the COVID-19 pandemic has led Cure SMA to reschedule its Annual SMA Conference and related events as virtual gatherings. Please save the date for Cure SMA’s first-ever virtual SMA Research & Clinical Care Meeting, taking place June 10-12, 2020. More information regarding the agenda and session registration is available on the meeting’s website.

Check out Meeting website

Submit a Presentation Abstract

Abstract submission for the 2020 SMA Research & Clinical Care Meeting is closed. Notification of acceptance will occur soon, as we are in the process of converting our program to virtual. We have asked that all abstract submissions for talks be on new and unpublished data. Talk selection will be based on the content of your abstract. More details will be provided upon notification of abstract acceptance.

Abstract Submission Closed

Goals for SMA Research & Clinical Care Meeting

  • Create open communication of early, unpublished scientific data, accelerating the pace of research.

  • Foster collaborations, including cross-disciplinary knowledge sharing, integration of researchers and drug companies, and dialogue among new and leading clinicians.

  • Facilitate collaborative discussions between new and leading clinicians to achieve improved care for SMA.

  • Promote conversations between families and patients living with SMA, clinicians, researchers, and industry partners.